Trial Profile
Phase 4 Study of PPSV23 Pneumococcal Vaccine in COPD Patients Using High Daily Dose of Inhaled Corticosteroid
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jun 2011
Price :
$35
*
At a glance
- Drugs Pneumococcal vaccine (Primary) ; Budesonide; Fluticasone propionate
- Indications Chronic obstructive pulmonary disease; Pneumonia
- Focus Therapeutic Use
- 29 Jun 2011 New trial record